The Rx Research Corner is a blog written by the Research Team at PCMA. This blog will take a closer look at complex data and new research findings. Topics cover the PBM and prescription drug space and range from pricing, to policies, and to patient issues such as access and equity.
Missing from the VI Debate: Data That Shows It’s A Problem
By Amanda Frost, PhD Vice President, Research, PCMA Concerns about high health care costs are prevalent and appropriate, but can be often focused on the wrong place. Vertical integration (VI) is one area that is receiving attention from state and federal policymakers, with a focus on health insurers, pharmacy benefit managers (PBMs), and
The Trillion-Dollar Blind Spot – How Influential Wholesalers Have Stayed in the Shadows
By Amanda Frost, PhD Vice President, Research, PCMA Federal and state policymakers have been focused lately on pharmacy benefit managers (PBMs), and sweeping industry
Drug Companies Continue to Set High Prescription Drug Launch Prices
More than six decades ago, the battle against high drug prices began, and that fight is far from over.
Innovation That Puts Patients First
Every year, like clockwork, drug prices go up. For many patients, those increases aren’t just numbers on a chart; they’re real barriers to getting the care they need. That’s where pharmacy benefit managers (PBMs) come in, helping to mitigate the financial pressures and barriers to access that come with high drug prices.
Dispensing Fee Mandates Increase Drug Spending; Here Is the Data
West Virginia dispensing fee law is a warning of the effects of mandated reimbursements.
New PCMA Data Resource Webpages
New PCMA webpages will make more data available and other resources more accessible.